EVO Stock Analysis: Buy, Sell, or Hold?
EVO - Evotec SE American Depositary Shares
$3.79
0.37 (10.82%)
▲
5d:
+3.55%
30d:
+19.18%
90d:
-6.88%
HOLD
MODERATE Confidence
Last Updated: February 3, 2026
Earnings: Apr 01, 2026
Get Alerted When EVO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: EVO shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: EVO shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: EVO is currently trading at $3.79, which is considered extended relative to its 30-day fair value range of $3.28 to $3.76.
Technical Outlook: Technically, EVO is in a downtrend. The price is approaching resistance at $3.82. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 10.8% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $5.61 (+47.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, EVO is in a downtrend. The price is approaching resistance at $3.82. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 10.8% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $5.61 (+47.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$3.28 -
$3.76
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
56.3%
All Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+10.8%)
- BULLISH: Trading 47.9% below Wall St target ($5.61)
Fair Price Analysis
30-Day Fair Range
$3.28 -
$3.76
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$3.38
Resistance Level
$3.82
Current Trend
Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-10.53
Wall Street Target
$5.61
(+47.9%)
Revenue Growth (YoY)
-11.4%
Profit Margin
-21.0%
Last updated: February 03, 2026 6:44 PM ET
Data refreshes hourly during market hours. Next update: 7:44 PM
Data refreshes hourly during market hours. Next update: 7:44 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is EVO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$180 | 65 BUY |
|
ZTS
Zoetis Inc |
STRONG BUY
19 analysts |
$154 | 58 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$83 | 57 HOLD |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$22 | 57 HOLD |
|
TEVA
Teva Pharma Industries L… |
STRONG BUY
11 analysts |
$37 | 59 HOLD |
